{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:39:26Z","timestamp":1792715966488,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":102,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02225-w","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:32:24Z","timestamp":1783949544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of vitamin D supplementation on the liver function in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"18","author":[{"given":"Mahdi","family":"Vajdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Nikrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Khajeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooshin","family":"Noshadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Maroofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Darzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Pourteymour Fard Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"9","key":"2225_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"2225_CR2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.21037\/hbsn-23-548","volume":"12","author":"R Manikat","year":"2023","unstructured":"Manikat R, Ahmed A, Kim D. Up-to-date global epidemiology of nonalcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2023;12(6):956\u20139.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"2225_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2225_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.metabol.2017.04.011","volume":"72","author":"I Reccia","year":"2017","unstructured":"Reccia I, Kumar J, Akladios C, Virdis F, Pai M, Habib N, et al. Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism. 2017;72:94\u2013108.","journal-title":"Metabolism"},{"issue":"2","key":"2225_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","volume":"20","author":"DE Kleiner","year":"2016","unstructured":"Kleiner DE, Makhlouf HR. Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children. Clin Liver Dis. 2016;20(2):293\u2013312.","journal-title":"Clin Liver Dis"},{"issue":"9","key":"2225_CR6","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut. 2020;69(9):1691\u2013705.","journal-title":"Gut"},{"issue":"3","key":"2225_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547\u201355.","journal-title":"Gastroenterology"},{"issue":"6","key":"2225_CR8","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.23527","volume":"51","author":"MS Ascha","year":"2010","unstructured":"Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51(6):1972\u20138.","journal-title":"Hepatology"},{"issue":"4","key":"2225_CR9","doi-asserted-by":"publisher","first-page":"e1003100","DOI":"10.1371\/journal.pmed.1003100","volume":"17","author":"H Jarvis","year":"2020","unstructured":"Jarvis H, Craig D, Barker R, Spiers G, Stow D, Anstee QM, et al. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. PLoS Med. 2020;17(4):e1003100.","journal-title":"PLoS Med"},{"issue":"1","key":"2225_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker RG, Hayden MS, Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011;13(1):11\u201322.","journal-title":"Cell Metab"},{"key":"2225_CR11","doi-asserted-by":"crossref","unstructured":"Hong SH, Choi KM. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. Int J Mol Sci. 2020;21(2) :494.","DOI":"10.3390\/ijms21020494"},{"issue":"5","key":"2225_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/01.HYP.0000163475.04421.e4","volume":"45","author":"DB Savage","year":"2005","unstructured":"Savage DB, Petersen KF, Shulman GI. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension. 2005;45(5):828\u201333.","journal-title":"Hypertension"},{"issue":"3","key":"2225_CR13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1172\/JCI134165","volume":"130","author":"GI Smith","year":"2020","unstructured":"Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW, et al. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Invest. 2020;130(3):1453\u201360.","journal-title":"J Clin Invest"},{"issue":"4","key":"2225_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","volume":"13","author":"ME Rinella","year":"2016","unstructured":"Rinella ME, Sanyal AJ. Management of NAFLD: a stage-based approach. Nat Rev Gastroenterol Hepatol. 2016;13(4):196\u2013205.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"2225_CR15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/joim.13531","volume":"292","author":"R Paternostro","year":"2022","unstructured":"Paternostro R, Trauner M. Current treatment of non-alcoholic fatty liver disease. J Intern Med. 2022;292(2):190\u2013204.","journal-title":"J Intern Med"},{"issue":"6","key":"2225_CR16","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s00125-016-3952-1","volume":"59","author":"K Cusi","year":"2016","unstructured":"Cusi K. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. Diabetologia. 2016;59(6):1112\u201320.","journal-title":"Diabetologia"},{"issue":"1","key":"2225_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.24376","volume":"54","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54(1):344\u201353.","journal-title":"Hepatology"},{"key":"2225_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.07.007","volume":"181","author":"DB Jump","year":"2018","unstructured":"Jump DB, Lytle KA, Depner CM, Tripathy S. Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. Pharmacol Ther. 2018;181:108\u201325.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2225_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11926-008-0020-y","volume":"10","author":"N Khazai","year":"2008","unstructured":"Khazai N, Judd SE, Tangpricha V. Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep. 2008;10(2):110\u20137.","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"2225_CR20","doi-asserted-by":"publisher","first-page":"102350","DOI":"10.1016\/j.autrev.2019.102350","volume":"18","author":"G Murdaca","year":"2019","unstructured":"Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F, et al. Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications. Autoimmun Rev. 2019;18(9):102350.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"2225_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1586\/eri.10.102","volume":"8","author":"J Bartley","year":"2010","unstructured":"Bartley J, Vitamin D. emerging roles in infection and immunity. Expert Rev Anti Infect Ther. 2010;8(12):1359\u201369.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"2225_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12931-022-02147-x","volume":"23","author":"M Gaudet","year":"2022","unstructured":"Gaudet M, Plesa M, Mogas A, Jalaleddine N, Hamid Q, Al Heialy S. Recent advances in vitamin D implications in chronic respiratory diseases. Respir Res. 2022;23(1):252.","journal-title":"Respir Res"},{"key":"2225_CR23","doi-asserted-by":"publisher","first-page":"106484","DOI":"10.1016\/j.phrs.2022.106484","volume":"186","author":"E Moslemi","year":"2022","unstructured":"Moslemi E, Musazadeh V, Kavyani Z, Naghsh N, Shoura SMS, Dehghan P. Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis. Pharmacol Res. 2022;186:106484.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2225_CR24","doi-asserted-by":"publisher","first-page":"12343","DOI":"10.1038\/s41598-023-39469-9","volume":"13","author":"X Lei","year":"2023","unstructured":"Lei X, Zhou Q, Wang Y, Fu S, Li Z, Chen Q. Serum and supplemental vitamin D levels and insulin resistance in T2DM populations: a meta-analysis and systematic review. Sci Rep. 2023;13(1):12343.","journal-title":"Sci Rep"},{"key":"2225_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms21186644","volume":"21","author":"I Szymczak-Pajor","year":"2020","unstructured":"Szymczak-Pajor I, Drzewoski J, Sliwinska A. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int J Mol Sci. 2020;21:18.","journal-title":"Int J Mol Sci"},{"key":"2225_CR26","doi-asserted-by":"publisher","first-page":"7643542","DOI":"10.1155\/2019\/7643542","volume":"2019","author":"S Zhu","year":"2019","unstructured":"Zhu S, Wang Y, Luo F, Liu J, Xiu L, Qin J, et al. The Level of Vitamin D in Children and Adolescents with Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Biomed Res Int. 2019;2019:7643542.","journal-title":"Biomed Res Int"},{"issue":"2","key":"2225_CR27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.cgh.2022.01.021","volume":"21","author":"S Yuan","year":"2023","unstructured":"Yuan S, Larsson SC. Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2023;21(2):398\u2013e4054.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2225_CR28","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.1038\/s41598-022-11950-x","volume":"12","author":"DA Sindhughosa","year":"2022","unstructured":"Sindhughosa DA, Wibawa IDN, Mariadi IK, Somayana G. Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis. Sci Rep. 2022;12(1):7716.","journal-title":"Sci Rep"},{"issue":"1","key":"2225_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/1735-9066.174759","volume":"21","author":"M Foroughi","year":"2016","unstructured":"Foroughi M, Maghsoudi Z, Askari G. The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD). Iran J Nurs Midwifery Res. 2016;21(1):100\u20134.","journal-title":"Iran J Nurs Midwifery Res"},{"issue":"3 Special","key":"2225_CR30","first-page":"1343","volume":"32","author":"M Hussain","year":"2019","unstructured":"Hussain M, Iqbal J, Malik SA, Waheed A, Shabnum S, Akhtar L, et al. Effect of vitamin D supplementation on various parameters in non-alcoholic fatty liver disease patients. Pak J Pharm Sci. 2019;32(3 Special):1343\u20138.","journal-title":"Pak J Pharm Sci"},{"issue":"1","key":"2225_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40360-021-00485-y","volume":"22","author":"H Yaghooti","year":"2021","unstructured":"Yaghooti H, Ghanavati F, Seyedian SS, Cheraghian B, Mohammadtaghvaei N. The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism. BMC Pharmacol Toxicol. 2021;22(1):18.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"4","key":"2225_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/19390211.2019.1624671","volume":"17","author":"F Mansour-Ghanaei","year":"2020","unstructured":"Mansour-Ghanaei F, Pourmasoumi M, Hadi A, Ramezani-Jolfaie N, Joukar F. The Efficacy of Vitamin D Supplementation against Nonalcoholic Fatty Liver Disease: A Meta-Analysis. J Diet Suppl. 2020;17(4):467\u201385.","journal-title":"J Diet Suppl"},{"issue":"11","key":"2225_CR33","first-page":"Cd011564","volume":"11","author":"G Bjelakovic","year":"2017","unstructured":"Bjelakovic G, Nikolova D, Bjelakovic M, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev. 2017;11(11):Cd011564.","journal-title":"Cochrane Database Syst Rev"},{"key":"2225_CR34","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). cochrane. 2023."},{"key":"2225_CR35","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"2225_CR36","doi-asserted-by":"crossref","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. John Wiley & Sons: West Sussex, UK. 2009.","DOI":"10.1002\/9780470743386"},{"key":"2225_CR37","unstructured":"TNC C. Review Manager (RevMan) Copenhagen: The Cochrane Collaboration. 2014."},{"key":"2225_CR38","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"issue":"10","key":"2225_CR39","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","volume":"61","author":"JL Peters","year":"2008","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61(10):991\u20136.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"2225_CR40","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","volume":"53","author":"JA Sterne","year":"2000","unstructured":"Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53(11):1119\u201329.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"2225_CR41","first-page":"969","volume":"5","author":"M Foroughi","year":"2014","unstructured":"Foroughi M, Maghsoudi Z, Ghiasvand R, Iraj B, Askari G. Effect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver. Int J Prev Med. 2014;5(8):969\u201375.","journal-title":"Int J Prev Med"},{"key":"2225_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12916-016-0638-y","volume":"14","author":"I Barchetta","year":"2016","unstructured":"Barchetta I, Del Ben M, Angelico F, Di Martino M, Fraioli A, La Torre G, et al. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. BMC Med. 2016;14:92.","journal-title":"BMC Med"},{"issue":"9","key":"2225_CR43","first-page":"631","volume":"19","author":"H Lorvand Amiri","year":"2016","unstructured":"Lorvand Amiri H, Agah S, Mousavi SN, Hosseini AF, Shidfar F. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial. Arch Iran Med. 2016;19(9):631\u20138.","journal-title":"Arch Iran Med"},{"issue":"6","key":"2225_CR44","first-page":"410","volume":"14","author":"A Nadjarzadeh","year":"2016","unstructured":"Nadjarzadeh A, Jani N, Khoshnevisan M, Molajaafari A, Fallahzadeh H, Khabiri F, et al. Effects of low caloric diet with and without vitamin D supplementation on anthropometric parameters in patients with non-alcoholic fatty liver. Tolooebehdasht. 2016;14(6):410\u201322.","journal-title":"Tolooebehdasht"},{"issue":"8","key":"2225_CR45","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1177\/1535370216629009","volume":"241","author":"N Sharifi","year":"2016","unstructured":"Sharifi N, Amani R, Hajiani E, Cheraghian B. Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkers. Experimental biology Med. 2016;241(8):830\u20138.","journal-title":"Experimental biology Med"},{"issue":"2","key":"2225_CR46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jgh3.12010","volume":"1","author":"M Sakpal","year":"2017","unstructured":"Sakpal M, Satsangi S, Mehta M, Duseja A, Bhadada S, Das A, et al. Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial. JGH Open. 2017;1(2):62\u20137.","journal-title":"JGH Open"},{"issue":"4","key":"2225_CR47","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.dsx.2018.03.006","volume":"12","author":"MH Dabbaghmanesh","year":"2018","unstructured":"Dabbaghmanesh MH, Danafar F, Eshraghian A, Omrani GR. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial. Diabetes Metab Syndr. 2018;12(4):513\u20137.","journal-title":"Diabetes Metab Syndr"},{"key":"2225_CR48","unstructured":"Hosseini S, Aliashrafi S, Ebrahimi-Mameghani M. The Effect of a Single Intramuscular Injection of Cholecalciferol on the Serum Levels of Vitamin D, Adiponectin, Insulin Resistance, and Liver Function in Women with Non-Alcoholic Fatty Liver Disease (NAFLD): A Randomized, Controlled Clinical Trial. Iranian Red Crescent Medical Journal. 2018;In Press."},{"key":"2225_CR49","first-page":"415","volume":"34","author":"T Taghavaei","year":"2018","unstructured":"Taghavaei T, Akha o, Mouodi M, Tirgar-fakheri H, Kashi Z, Maleki I, et al. Effects of Vitamin D Supplementation on Patients with Non\u2013 alcoholic Fatty Liver Disease (NAFLD). Acta Med Mediterranea. 2018;34:415.","journal-title":"Acta Med Mediterranea"},{"issue":"1","key":"2225_CR50","first-page":"496","volume":"18","author":"F Shidfar","year":"2019","unstructured":"Shidfar F, Mousavi SN, Lorvand Amiri H, Agah S, Hoseini S, Hajimiresmail SJ. Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial. Iran J Pharm Res. 2019;18(1):496\u2013505.","journal-title":"Iran J Pharm Res"},{"issue":"11","key":"2225_CR51","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/dom.14129","volume":"22","author":"V Lukenda Zanko","year":"2020","unstructured":"Lukenda Zanko V, Domislovic V, Trkulja V, Krznaric-Zrnic I, Turk-Wensveen T, Krznaric Z, et al. Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab. 2020;22(11):2097\u2013106.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2225_CR52","first-page":"44","volume":"14","author":"AI Gad","year":"2021","unstructured":"Gad AI, Elmedames MR, Abdelhai AR, Marei AM, Abdel-Ghani HA. Efficacy of vitamin D supplementation on adult patients with non-alcoholic fatty liver disease: a single-center experience. Gastroenterol Hepatol Bed Bench. 2021;14(1):44\u201352.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"4","key":"2225_CR53","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00394-021-02772-0","volume":"61","author":"XF Guo","year":"2022","unstructured":"Guo XF, Wang C, Yang T, Ma WJ, Zhai J, Zhao T, et al. The effects of fish oil plus vitamin D(3) intervention on non-alcoholic fatty liver disease: a randomized controlled trial. Eur J Nutr. 2022;61(4):1931\u201342.","journal-title":"Eur J Nutr"},{"key":"2225_CR54","doi-asserted-by":"publisher","first-page":"1149967","DOI":"10.3389\/fphar.2023.1149967","volume":"14","author":"AA Mohamed","year":"2023","unstructured":"Mohamed AA, Halim AA, Mohamed S, Mahmoud SM, Bahgat Eldemiry EM, Mohamed RS, et al. The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial. Front Pharmacol. 2023;14:1149967.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2225_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12876-022-02457-w","volume":"22","author":"Z Rahimpour","year":"2022","unstructured":"Rahimpour Z, Hoseini R, Behpour N. Alterations of liver enzymes and lipid profile in response to exhaustive eccentric exercise: vitamin D supplementation trial in overweight females with non-alcoholic fatty liver disease. BMC Gastroenterol. 2022;22(1):372.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"2225_CR56","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/biof.1496","volume":"45","author":"H Tavakoli","year":"2019","unstructured":"Tavakoli H, Rostami H, Avan A, Bagherniya M, Ferns GA, Khayyatzadeh SS, et al. High dose vitamin D supplementation is associated with an improvement in serum markers of liver function. BioFactors. 2019;45(3):335\u201342.","journal-title":"BioFactors"},{"issue":"9","key":"2225_CR57","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1039\/D0FO01095B","volume":"11","author":"X-f Guo","year":"2020","unstructured":"Guo X-f, Wang C, Yang T, Li S, Li K-l, Li D. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Food Funct. 2020;11(9):7389\u201399.","journal-title":"Food Funct"},{"key":"2225_CR58","doi-asserted-by":"crossref","unstructured":"Wei Y, Wang S, Meng Y, Yu Q, Wang Q, Xu H et al. Effects of vitamin D supplementation in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Int J Endocrinol metabolism. 2020;18(3) :e97205.","DOI":"10.5812\/ijem.97205"},{"issue":"15","key":"2225_CR59","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.3390\/jcm10153311","volume":"10","author":"AH Ali","year":"2021","unstructured":"Ali AH, Petroski GF, Diaz-Arias AA, Al Juboori A, Wheeler AA, Ganga RR, et al. A model incorporating serum alkaline phosphatase for prediction of liver fibrosis in adults with obesity and nonalcoholic fatty liver disease. J Clin Med. 2021;10(15):3311.","journal-title":"J Clin Med"},{"key":"2225_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.clnesp.2020.11.005","volume":"41","author":"S-A Tabatabaeizadeh","year":"2021","unstructured":"Tabatabaeizadeh S-A, Tafazoli N. The role of vitamin D in prevention of type 2 diabetes. A meta-analysis. Clin Nutr ESPEN. 2021;41:88\u201393.","journal-title":"Clin Nutr ESPEN"},{"issue":"20","key":"2225_CR61","doi-asserted-by":"publisher","first-page":"15485","DOI":"10.3390\/ijms242015485","volume":"24","author":"C Argano","year":"2023","unstructured":"Argano C, Mirarchi L, Amodeo S, Orlando V, Torres A, Corrao S. The role of vitamin D and its molecular bases in insulin resistance, diabetes, metabolic syndrome, and cardiovascular disease: state of the art. Int J Mol Sci. 2023;24(20):15485.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2225_CR62","first-page":"44","volume":"14","author":"AI Gad","year":"2021","unstructured":"Gad AI, Elmedames MR, Abdelhai AR, Marei AM, Abdel-Ghani HA. Efficacy of vitamin D supplementation on adult patients with non-alcoholic fatty liver disease: a single-center experience. Gastroenterol Hepatol Bed Bench. 2021;14(1):44.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"2225_CR63","doi-asserted-by":"crossref","unstructured":"Kim GH, Jeong H-J, Lee YJ, Park HY, Koo SK, Lim JH. Vitamin D ameliorates age-induced nonalcoholic fatty liver disease by increasing the mitochondrial contact site and cristae organizing system (MICOS) 60 level. Exp Mol Med. 2024;56(1):142-55 .","DOI":"10.1038\/s12276-023-01125-7"},{"key":"2225_CR64","doi-asserted-by":"crossref","unstructured":"Mikhailova A, Lagutina D, Golovatuk K, Chernikova A, Vasilieva EY, Karonova T, editors. Cholecalciferol supplementation effect on vitamin D metabolism parameters in hospitalized covid-19 patients. Endocrine Abstracts; 2023: Bioscientifica.","DOI":"10.1530\/endoabs.90.EP167"},{"key":"2225_CR65","doi-asserted-by":"crossref","unstructured":"Bjelakovic M, Nikolova D, Bjelakovic G, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Reviews. 2021;8(8):CD011564 .","DOI":"10.1002\/14651858.CD011564.pub3"},{"issue":"4","key":"2225_CR66","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10519-013-9593-y","volume":"43","author":"JH van Beek","year":"2013","unstructured":"van Beek JH, de Moor MH, de Geus EJ, Lubke GH, Vink JM, Willemsen G, et al. The genetic architecture of liver enzyme levels: GGT, ALT and AST. Behav Genet. 2013;43(4):329\u201339.","journal-title":"Behav Genet"},{"key":"2225_CR67","doi-asserted-by":"publisher","first-page":"732496","DOI":"10.3389\/fphar.2021.732496","volume":"12","author":"S Rezaei","year":"2021","unstructured":"Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, Jalali M, Shabani-Borujeni M, Modaresi S, et al. The effects of vitamin D supplementation on anthropometric and biochemical indices in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Pharmacol. 2021;12:732496.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2225_CR68","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1038\/s41467-025-59724-z","volume":"16","author":"EB Baek","year":"2025","unstructured":"Baek EB, Eun HS, Song J-Y, Hong E-J, Park S-H, Kumbukgahadeniya P, et al. Vitamin D supplementation ameliorates ductular reaction, liver inflammation and fibrosis in mice by upregulating TXNIP in ductular cells. Nat Commun. 2025;16(1):4420.","journal-title":"Nat Commun"},{"issue":"2","key":"2225_CR69","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.aohep.2019.08.004","volume":"19","author":"D Iluz-Freundlich","year":"2020","unstructured":"Iluz-Freundlich D, Zhang M, Uhanova J, Minuk GY. The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease. Ann Hepatol. 2020;19(2):204\u20138.","journal-title":"Ann Hepatol"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02225-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02225-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02225-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:03:08Z","timestamp":1792713788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02225-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2225"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02225-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol for this study was registered in the PROSPERO system (CRD42024545499) and approved by the Ethics Committee of Isfahan University of Medical Sciences (IR.MUI.PHANUT.REC.1405.066).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"223"}}